These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 4412470)
1. Clinical experience and experimental findings with sodium fluoride in otosclerosis (otospongiosis). Causse J; Chevance LG; Shambaugh GE Ann Otol Rhinol Laryngol; 1974; 83(5):643-7. PubMed ID: 4412470 [No Abstract] [Full Text] [Related]
2. Enzymology of otospongiosis and NaF therapy. Causse JR; Shambaugh GE; Causse B; Bretlau P Am J Otol; 1980 Apr; 1(4):206-14. PubMed ID: 6969991 [No Abstract] [Full Text] [Related]
3. The effect of sodium fluoride on otosclerotic activity as determined by strontium. Linthicum FH; House HP; Althaus SR Ann Otol Rhinol Laryngol; 1973; 82(4):609-15. PubMed ID: 4721187 [No Abstract] [Full Text] [Related]
4. [Biological bases for a fluoride treatment of otospongiosis. Experimental and clinical results]. Causse J; Chevance LG Ann Otolaryngol Chir Cervicofac; 1973 Mar; 90(3):139-60. PubMed ID: 4717370 [No Abstract] [Full Text] [Related]
6. Ten years experience with fluoride in otosclerotic (otospongiotic) patients. Shambaugh GE; Causse J Ann Otol Rhinol Laryngol; 1974; 83(5):635-42. PubMed ID: 4416065 [No Abstract] [Full Text] [Related]
7. Sensorineural deafness due to cochlear otospongiosis: pathogenesis, clinical diagnosis, and therapy. Shambaugh GE Otolaryngol Clin North Am; 1978 Feb; 11(1):135-54. PubMed ID: 662341 [No Abstract] [Full Text] [Related]
8. The possible value of sodium fluoride for inactivation of the otosclerotic bone lesion. Experimental and clinical studies. Shambaugh GE; Petrovic A Acta Otolaryngol; 1967 Apr; 63(4):331-9. PubMed ID: 6033657 [No Abstract] [Full Text] [Related]
10. [What may be expected from the therapy of otosclerosis using sodium fluoride?]. Chládek V; Slaninová B Cesk Otolaryngol; 1977 Oct; 26(5):267-71. PubMed ID: 603948 [No Abstract] [Full Text] [Related]
12. Surgical and medical treatment of hearing loss in mixed otosclerosis. Félix-Trujillo MM; Valdez-Martínez E; Ramírez JE; Lozano-Morales R Ann Otol Rhinol Laryngol; 2009 Dec; 118(12):859-65. PubMed ID: 20112520 [TBL] [Abstract][Full Text] [Related]
13. Medical therapy of otospongiosis. Shambaugh GE Acta Otorhinolaryngol Belg; 1981; 35(5-6):390-403. PubMed ID: 7347082 [No Abstract] [Full Text] [Related]
14. Fluoride therapy for cochlear otosclerosis? an audiometric and computerized tomography evaluation. Derks W; De Groot JA; Raymakers JA; Veldman JE Acta Otolaryngol; 2001 Jan; 121(2):174-7. PubMed ID: 11349772 [TBL] [Abstract][Full Text] [Related]
15. [Use of fluorine in otosclerosis (review of the foreign literature]. Gukovich VA Zh Ushn Nos Gorl Bolezn; 1971; 31(1):117-21. PubMed ID: 4942008 [No Abstract] [Full Text] [Related]
17. Fluorides for otospongiosis and other osteoporotic states. Shambaugh GE Ann Otolaryngol Chir Cervicofac; 1973 Mar; 90(3):129-38. PubMed ID: 4717369 [No Abstract] [Full Text] [Related]
18. New concepts in management of otospongiosis. Shambaugh GE; causse J; Petrovic A; Chevance LG; Valvassori GE Arch Otolaryngol; 1974 Dec; 100(6):419-26. PubMed ID: 4447481 [No Abstract] [Full Text] [Related]
19. Experimental studies on pathology and therapy of otospongiosis. Petrovic AG; Stutzmann JJ; Shambaugh GE Am J Otol; 1985 Jan; 6(1):43-50. PubMed ID: 2983562 [No Abstract] [Full Text] [Related]